Actigraphy devices market seen reaching $3.9 billion by 2030

The Business Research Company says the global actigraphy devices market will grow from $2.81 billion in 2026 to $3.9 billion by 2030 as sleep disorder diagnoses, wearable health tech and remote monitoring expand. North America led in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Actigraphy devices support sleep and activity monitoring without invasive testing, making them useful for diagnosing sleep disorders and tracking circadian rhythm disruption. - Rising sleep problems and broader use of wearables are pushing demand for continuous, objective sleep data in both clinical and home settings.

What happened: - The Business Research Company published its Actigraphy Devices Market Report 2026, covering market size, trends and a global forecast through 2035. - The report says the market will grow from $2.59 billion in 2025 to $2.81 billion in 2026. - The report projects the market will reach $3.9 billion by 2030. - North America was the largest actigraphy devices market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also offered a free sample of the report and a full report.

The details: - Actigraphy devices are wearable, non-invasive instruments that measure physical activity and rest cycles over long periods. - The devices detect movement to monitor sleep-wake patterns and activity levels. - Continuous tracking gives healthcare providers objective data to assess sleep quality and guide treatment decisions. - The 2026 to 2030 expansion is expected to come from remote patient monitoring, deeper integration with digital health platforms, personalized sleep therapy, expanded clinical trial use and preventive sleep health management. - Expected market trends include wider use of wearable sleep trackers, more actigraphy data inside mobile health apps, demand for long-term sleep monitoring, more clinical and home-based monitoring services, and better data precision and patient adherence. - The report says earlier growth has been driven by more sleep disorder cases, greater awareness of circadian rhythm health, more sleep research, wider use of wearable health gadgets and demand for non-invasive diagnostic tools. - The report points to screen time as a factor that can worsen sleep by disrupting circadian rhythms through blue light exposure and melatonin suppression. - A November 2023 UK National Health Service report found 37.8% of children ages 8 to 16 had sleep problems at least three times in the prior week. - The same NHS report found sleep issues affected 76.5% of people likely suffering from mental disorders and 25.0% of those without mental health conditions.

Between the lines: - The market outlook suggests actigraphy is moving from a niche sleep-assessment tool toward a broader role in digital health and long-term patient monitoring. - Growth in home-based care and mobile health tools could make actigraphy data more accessible outside specialist sleep clinics. - The regional split suggests mature demand in North America and faster adoption potential in Asia-Pacific as awareness and wearable usage spread.

What's next: - The market is expected to keep expanding through 2030 as sleep monitoring becomes more connected to remote care, digital platforms and preventive health tools. - The report highlights more product and software integration opportunities around wearable trackers, mobile apps and long-duration monitoring. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards and market hotspot infographics. - The company also said updated graphics, tables and future trend analysis are included in the new reporting format.